Home › Research › Down syndrome and Alzheimer's
The role of magnetic resonance imaging in the diagnosis of Alzheimer disease in adults with Down syndrome
Prasher VP, Barber PC, West R, Glenholmes P.. Archives of neurology, 1996-12-01
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
Objective To correlate findings from magnetic resonance imaging (MRI) with neuropathological analysis and clinical assessment of Alzheimer disease in patients with Down syndrome. Design and methods Case study of 1 elderly man with trisomy 21 and Alzheimer disease who had been followed up prospectively over a 5-year period. The patient was a resident in a supervised community unit and died with end-stage dementia. The MRI changes were correlated with the results of clinical psychopathological analysis and neuropathological brain tissue findings. To our knowledge, this is the first case in which clinical, MRI, and neuropathological data were available in a case involving an elderly patient with Down syndrome and Alzheimer disease. Results The MRI findings correlated with the clinical deterioration and neuropathological features of Alzheimer disease. Marked changes in temporal and hippocampal regions were found. Conclusion Magnetic resonance imaging is potentially a valuable tool in the diagnosis of Alzheimer disease in adults with Down syndrome, particularly in individuals for whom standard intellectual assessments are not possible.
What this study adds
Evidence grade: Low
This single case study of one elderly man with Down syndrome and Alzheimer's disease found that MRI changes in temporal and hippocampal regions correlated with his clinical deterioration and with neuropathological findings of Alzheimer's disease. The authors conclude MRI is potentially a valuable diagnostic tool for Alzheimer's disease in adults with Down syndrome, particularly when standard intellectual assessments are not possible.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Prasher, V. P., Barber, P. C., West, R., & Glenholmes, P. (1996). The role of magnetic resonance imaging in the diagnosis of Alzheimer disease in adults with Down syndrome. Archives of neurology. https://doi.org/10.1001/archneur.1996.00550120122028
Vancouver
Prasher VP, Barber PC, West R, Glenholmes P. The role of magnetic resonance imaging in the diagnosis of Alzheimer disease in adults with Down syndrome. Archives of neurology. 1996. doi:10.1001/archneur.1996.00550120122028. PMID: 8970464.
BibTeX
@article{prasher1996-8970464,
author = {Prasher, V. P. and Barber, P. C. and West, R. and Glenholmes, P.},
title = {{The role of magnetic resonance imaging in the diagnosis of Alzheimer disease in adults with Down syndrome}},
journal = {Archives of neurology},
year = {1996},
doi = {10.1001/archneur.1996.00550120122028},
pmid = {8970464},
url = {https://doi.org/10.1001/archneur.1996.00550120122028}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- The MRI changes were correlated with the results of clinical psychopathological analysis and neuropathological brain tissue findings.
- Results The MRI findings correlated with the clinical deterioration and neuropathological features of Alzheimer disease.
Why it matters
This single case study of one elderly man with Down syndrome and Alzheimer's disease found that MRI changes in temporal and hippocampal regions correlated with his clinical deterioration and with neuropathological findings of Alzheimer's disease. The authors conclude MRI is potentially a valuable diagnostic tool for Alzheimer's disease in adults with Down syndrome, particularly when standard intellectual assessments are not possible.
Study details
- Evidence strengthLow
How this study scored 35/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported and randomized / blinded because the record does not state it. We have no data on senior author's track record, so that was left out: it earned 34 of the 96 points we could judge it on, which is 35 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Archives of neurology) |
| Journal's citation record | 3 / 4 | Archives of Neurology: journal h-index 353 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 1 / 5 | 1996 — older than 20 years, still counted |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 3 / 3 | Studied in people (pubmed indexes it as a clinical or observational study) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 3 / 7 | Cited 18 times (OpenAlex, 2026-10-10) |
| Citations per year | 0 / 5 | 0.6 citations a year over 32 year(s) since 1996 |
| Impact for its field and year | 2 / 6 | Cited 2.0× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 1 / 6 | Cited by 1 other studies in this library |
| Still being cited | 0 / 4 | Cited 0 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | — / 4 | OpenAlex's profile for last-listed author P. Glenholmes holds only 4 work(s), too few to judge a track record — left out of this score |
| Institution's track record | 1 / 3 | University of Birmingham: institution h-index 1,266 (OpenAlex) |
| Multicenter collaboration | 0 / 3 | OpenAlex lists 1 institution(s) in 1 country — scores zero (affiliation lists can be incomplete) |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 8970464) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Points | 34 / 96 | Scored on 19 of 20 parts. We have no data for the rest, so they are left out: 34 of the 96 points we could judge it on is 35 out of 100. |
| Total | 35 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
May need a subscription OpenAlex found no free copy of the full text (checked 6 Feb 1020), so the publisher may charge for it. The PubMed abstract is free.
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Later studies that cite this one
1 study in the alzhub library lists this one in its references.
Related studies in Down syndrome and Alzheimer's from nearby years
Also tagged “down”
527 studies in the library carry the topic tag “down”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 527 tagged studies.